Texas Children's Cancer Center, Department of Pediatrics Hematology/Oncology, Molecular and Cellular Biology, Baylor College of Medicine, 1102 Bates Avenue, Houston, TX, 77030, USA.
Cell Mol Life Sci. 2024 Feb 22;81(1):100. doi: 10.1007/s00018-024-05122-5.
Cell division is a crucial process, and one of its essential steps involves copying the genetic material, which is organized into structures called chromosomes. Before a cell can divide into two, it needs to ensure that each newly copied chromosome is paired tightly with its identical twin. This pairing is maintained by a protein complex known as cohesin, which is conserved in various organisms, from single-celled ones to humans. Cohesin essentially encircles the DNA, creating a ring-like structure to handcuff, to keep the newly synthesized sister chromosomes together in pairs. Therefore, chromosomal cohesion and separation are fundamental processes governing the attachment and segregation of sister chromatids during cell division. Metaphase-to-anaphase transition requires dissolution of cohesins by the enzyme Separase. The tight regulation of these processes is vital for safeguarding genomic stability. Dysregulation in chromosomal cohesion and separation resulting in aneuploidy, a condition characterized by an abnormal chromosome count in a cell, is strongly associated with cancer. Aneuploidy is a recurring hallmark in many cancer types, and abnormalities in chromosomal cohesion and separation have been identified as significant contributors to various cancers, such as acute myeloid leukemia, myelodysplastic syndrome, colorectal, bladder, and other solid cancers. Mutations within the cohesin complex have been associated with these cancers, as they interfere with chromosomal segregation, genome organization, and gene expression, promoting aneuploidy and contributing to the initiation of malignancy. In summary, chromosomal cohesion and separation processes play a pivotal role in preserving genomic stability, and aberrations in these mechanisms can lead to aneuploidy and cancer. Gaining a deeper understanding of the molecular intricacies of chromosomal cohesion and separation offers promising prospects for the development of innovative therapeutic approaches in the battle against cancer.
细胞分裂是一个至关重要的过程,其基本步骤之一是复制遗传物质,这些遗传物质组织成称为染色体的结构。在细胞分裂为两个之前,它需要确保每个新复制的染色体与其完全相同的双胞胎紧密配对。这种配对由一种称为黏合蛋白的蛋白质复合物维持,这种复合物在从单细胞到人类的各种生物体中都被保守。黏合蛋白本质上环绕着 DNA,形成一个环状结构,将新合成的姐妹染色体束缚在一起,使其配对。因此,染色体的凝聚和分离是控制细胞分裂过程中姐妹染色单体附着和分离的基本过程。有丝分裂到后期的转变需要酶 Seprase 溶解黏合蛋白。这些过程的严格调节对于保护基因组稳定性至关重要。染色体凝聚和分离的失调导致非整倍体,即细胞中染色体数量异常的一种情况,与癌症密切相关。非整倍体是许多癌症类型的常见特征,染色体凝聚和分离的异常已被确定为多种癌症的重要贡献因素,如急性髓性白血病、骨髓增生异常综合征、结直肠癌、膀胱癌和其他实体癌。黏合蛋白复合物中的突变与这些癌症有关,因为它们干扰了染色体分离、基因组组织和基因表达,促进了非整倍体的产生,并有助于恶性肿瘤的发生。总之,染色体凝聚和分离过程在维持基因组稳定性方面起着关键作用,这些机制的异常会导致非整倍体和癌症。深入了解染色体凝聚和分离的分子复杂性为开发对抗癌症的创新治疗方法提供了有希望的前景。